Aj. Ganzhorn et al., INHIBITION OF MYOINOSITOL MONOPHOSPHATASE ISOFORMS BY AROMATIC PHOSPHONATES, Bioorganic & medicinal chemistry, 6(10), 1998, pp. 1865-1874
alpha-Hydroxyphosphonates are moderately potent (K-i = 6-600 mu M) inh
ibitors of the enzyme myo-inositol monophosphatase (McLeod et al., Med
. Chem. Res. 1992, 2, 96). -[4-(5,6,7,8-tetrahydronaphtyl-1-oxy)phenyl
]methyl phosphonate (3) was resynthesized and its inhibitory potency t
owards the recombinant bovine brain enzyme confirmed (K-i = 20 mu M).
Similar aromatic difluoro-, keto-, and ketodifluorophosphonates (5, 7,
9) were inactive. Compound 3 was 15-fold less active on the human as
compared to the bovine enzyme. Molecular modeling suggested that the h
ydrophobic part of the inhibitor interacts with amino acid side chains
that are located at the interface between the enzyme subunits in an a
rea (amino acids 175-185) with low similarity between the two isozymes
. Phe-183 in the human enzyme was replaced with leucine, the correspon
ding residue in the bovine isoform. The three isozymes (human wildtype
, bovine wild-type and human F183L) had similar kinetic properties, ex
cept that the bovine enzyme was less effectively inhibited by high con
centrations of the activator Mg2+. The F183L mutant enzyme had a twofo
ld increased affinity for compound 3 as compared to the human wild-typ
e form. We conclude that residue 183 contributes to the binding of aro
matic hydroxyphosphonates to IMPase, but it is not the only determinin
g factor for inhibitor specificity with respect to different isozymes.
(C) 1998 Elsevier Science Ltd. All rights reserved.